• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Alcatel-Lucent 'B' Long-Term Rating Affirmed On Higher-Than-Expected Debt Issue, Off Watch; Outlook Negative Feb 13

  • ID: 2417850
  • February 2013
  • Standard & Poors


  • Alcatel-Lucent
  • Alcatel-Lucent USA Inc.
  • MORE

Alcatel-Lucent has raised €2.0 billion (equivalent) via senior secured facilities at its subsidiary Alcatel-Lucent USA Inc., which is €0.4 billion more than we expected. The positive impact of this debt issue on the group's liquidity, and cash balances that were somewhat higher than we expected at year-end 2012, are largely offsetting our expectations of continued significant cash losses in 2013. We are affirming our 'B' long-term ratings on Alcatel-Lucent and Alcatel-Lucent USA and removing them from CreditWatch negative. The negative outlook reflects the possibility of a downgrade over the next 12 months if the group's currently adequate liquidity is impaired by continued significantly negative cash losses or substantial redemptions of debt maturities beyond 2015. FRANKFURT (Standard & Poor's) Feb. 18,...

Companies mentioned in this report are:
- Alcatel-Lucent
- Alcatel-Lucent USA Inc.

Action: Affirmed
Action: On CreditWatch:Negative
Action: Removed From CreditWatch

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, READ MORE >

Note: Product cover images may vary from those shown

- Alcatel-Lucent
- Alcatel-Lucent USA Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.